In a prior MESA study comparing the predictive value of GlycA and other inflammatory biomarkers, GlycA had a significantly predictive value comparable to hsCRP, IL-6, and D-dimer, if not superior, for total death, CVD, chronic inflammatory-related severe hospitalization and death, and total cancer [21]. Here, IL6 is linked to cancer.